We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AOSL icon
2251
Alpha and Omega Semiconductor
AOSL
$1.09B
$101K ﹤0.01%
+9,268
New +$95K
AKCA
2252
DELISTED
Akcea Therapeutics Inc
AKCA
$101K ﹤0.01%
7,356
CHMA
2253
DELISTED
Chiasma, Inc. Common Stock
CHMA
$101K ﹤0.01%
+18,705
New +$103K
WTI icon
2254
W&T Offshore
WTI
$555M
$101K ﹤0.01%
44,133
HMHC
2255
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$100K ﹤0.01%
55,337
+5,512
+11% +$8.85K
DSSI
2256
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$99.3K ﹤0.01%
12,429
CWCO icon
2257
Consolidated Water Co
CWCO
$505M
$99.1K ﹤0.01%
6,871
AGRX
2258
DELISTED
Agile Therapeutics
AGRX
$99.1K ﹤0.01%
+18
New +$93.5K
BYSI icon
2259
BeyondSpring
BYSI
$30.5M
$98.9K ﹤0.01%
6,560
TBCH
2260
Turtle Beach Corp
TBCH
$230M
$97.7K ﹤0.01%
+6,636
New +$68.4K
CPS icon
2261
Cooper-Standard Automotive
CPS
$490M
$97.3K ﹤0.01%
7,342
BFYT
2262
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$97.1K ﹤0.01%
4,748
EBTC
2263
DELISTED
Enterprise Bancorp
EBTC
$96.8K ﹤0.01%
4,064
SEI
2264
Solaris Energy Infrastructure
SEI
$4.07B
$96.7K ﹤0.01%
13,032
AVID
2265
DELISTED
Avid Technology Inc
AVID
$96.6K ﹤0.01%
13,287
YARW
2266
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$96.4K ﹤0.01%
+15
New +$102K
LFCR icon
2267
Lifecore Biomedical
LFCR
$181M
$96.3K ﹤0.01%
12,103
FOSL icon
2268
Fossil Group
FOSL
$311M
$96K ﹤0.01%
20,656
TDW icon
2269
Tidewater
TDW
$4.56B
$95.7K ﹤0.01%
17,119
GEF.B icon
2270
Greif Class B
GEF.B
$4.24B
$95.2K ﹤0.01%
2,277
TDAY
2271
USA Today Co
TDAY
$1.01B
$94.7K ﹤0.01%
68,596
+10,602
+18% +$14K
FENC icon
2272
Fennec Pharmaceuticals
FENC
$414M
$94.6K ﹤0.01%
+11,329
New +$84.3K
SMBK icon
2273
SmartFinancial
SMBK
$898M
$94.2K ﹤0.01%
5,821
AWH
2274
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$92.7K ﹤0.01%
+1,610
New +$107K
ARAY icon
2275
Accuray
ARAY
$33.4M
$92K ﹤0.01%
+45,332
New +$94.4K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.